Arbutus Biopharma Stock (NASDAQ: ABUS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.287M |
Day Range | - - - |
52 Wk Range | 1.690 - 3.290 |
Market Cap | $530.296M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 3.48% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arbutus Biopharma (NASDAQ: ABUS) through any online brokerage.
There are no as such competitors for Arbutus Biopharma.
The latest price target for Arbutus Biopharma (NASDAQ: ABUS) was reported by Chardan Capital on Friday, May 3, 2024. The analyst firm set a price target for 4.00 expecting ABUS to rise to within 12 months (a possible 42.35% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $2.81 last updated May 10, 2024 at 4:11 PM EDT.
There are no upcoming dividends for Arbutus Biopharma.
Arbutus Biopharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Arbutus Biopharma.
Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.